Generation of recombinant guinea pig antibody fragments to the human GABAC receptor

To generate monoclonal antibodies to the human ρ1 GABAC receptor, a ligand-gated chloride ion channel that is activated by the neurotransmitter γ-aminobutyric acid (GABA), we recovered the immunoglobulin variable heavy chain (VH) and light chain (VL) regions of a guinea pig immunized with a 14-mer p...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of immunological methods 2011-05, Vol.368 (1-2), p.36-44
Hauptverfasser: Memic, Adnan, Volgina, Veronica V., Gussin, Hélène A., Pepperberg, David R., Kay, Brian K.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:To generate monoclonal antibodies to the human ρ1 GABAC receptor, a ligand-gated chloride ion channel that is activated by the neurotransmitter γ-aminobutyric acid (GABA), we recovered the immunoglobulin variable heavy chain (VH) and light chain (VL) regions of a guinea pig immunized with a 14-mer peptide segment of the N-terminal extracellular domain of the ρ1 subunit. Oligonucleotide primers were designed and used to amplify the VH and VL regions of guinea pig RNA by the reverse transcriptase polymerase chain reaction. The amplified and cloned VH and VL regions were transferred together into a phagemid vector, yielding a library of 5×106 members, which displayed chimeric fragments of antigen binding (Fabs) with guinea pig variable and human constant regions fused to protein III of M13 bacteriophage. Through affinity selection of this phage-display library with the biotinylated 14-mer peptide segment of GABAC, we isolated four different antibody fragments that bound specifically to the immunogenic peptide. Phage particles displaying two of these antibodies, but not negative controls, bound selectively to the surface of neuroblastoma cells expressing the ρ1 GABAC receptor. Such antibody fragments will be useful in future studies involving targeting of specific neural tissues that express the GABAC receptor.
ISSN:0022-1759
1872-7905
DOI:10.1016/j.jim.2011.02.010